Acrivon Therapeutics (NASDAQ:ACRV) Now Covered by Maxim Grou

Analysts at Maxim Group assumed coverage on shares of Acrivon Therapeutics (NASDAQ:ACRV – Get Free Report) in a research report issued to clients and investors on Thursday, FlyOnTheWall reports. The brokerage set a “buy” rating on the stock. A number of other research analysts have also weighed in on ACRV. HC Wainwright reaffirmed a “buy” […]

Related Keywords

California , United States , New York , , York State Common Retirement Fund , Wells Fargo Company , Citigroup Inc , Barclays Plc , Acrivon Therapeutics Inc , Acrivon Therapeutics Company Profile , Analysts At Maxim Group , Maxim Group , Acrivon Therapeutics , Get Free Report , Therapeutics Stock Down , State Teachers Retirement System , Acrivon Predictive Precision Proteomics , Acrivon Therapeutics Daily , Nasdaq Acrv , Acrv , Medical , Initiated Coverage ,